A numerical trend toward higher complications, particularly major bleeding (11.4% vs. 3.4%), was observed in the half-dose group, although not statistically significant.
← all excerpts
A Non-randomized Clinical Trial on the Effectiveness and Complications of Two Different Streptokinase Dosages in Elderly Patients With ST-Elevation Myocardial Infarction (STEMI).
1
—
—